XML 38 R28.htm IDEA: XBRL DOCUMENT v3.22.2.2
Equity-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2022
Equity-Based Compensation  
Summary of the restricted stock

WEIGHTED-

AVERAGE

GRANT DATE

    

SHARES

    

FAIR VALUE

Non-vested restricted stock as of December 31, 2021

3,910,722

$

23.18

Granted

66,220

17.07

Vested

(1,772,239)

 

22.87

Forfeited

(229,854)

 

23.00

Cancelled

(66,220)

23.00

Non-vested restricted stock as of September 30, 2022

1,908,629

$

23.28

Summary of the Company's RSU activity

WEIGHTED-

AVERAGE 

GRANT DATE 

    

UNITS

    

FAIR VALUE

Non-vested RSUs as of December 31, 2021

 

1,288,724

$

29.28

Granted*

 

1,415,901

 

22.10

Vested**

 

(420,168)

 

28.52

Forfeited

 

(149,610)

 

24.87

Non-vested RSUs as of September 30, 2022

 

2,134,847

$

24.98

Schedule of nonvested Performance-based Units activity

WEIGHTED-

AVERAGE 

GRANT DATE 

    

UNITS

    

FAIR VALUE

Non-vested PSUs as of December 31, 2021

 

406,575

$

27.35

Granted

 

361,147

 

22.25

Vested

 

(12,291)

 

24.83

Forfeited

 

(57,077)

 

35.47

Non-vested PSUs as of September 30, 2022

 

698,354

$

24.10

Schedule of compensation expense

THREE MONTHS ENDED SEPTEMBER 30, 

NINE MONTHS ENDED SEPTEMBER 30, 

2022

    

2021

    

2022

    

2021

Cost of revenues

$

2,454

$

1,442

$

6,834

$

3,738

Sales and marketing

 

160

 

602

 

1,670

 

1,636

Research and development

 

957

 

514

 

4,115

 

1,528

General and administrative

 

3,233

 

5,607

 

11,199

 

13,944

Total

$

6,804

$

8,165

$

23,818

$

20,846